ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients

Several studies have evaluated the efficacy of neoadjuvant treatment using oxaliplatin and fluoropyrimidines in advanced gastric cancer (GC). However, preoperative biomarkers predictive of clinical outcome remain lacking. We examined polymorphisms in the MTHFR, DPYD, UMPS, ABCB1, ABCC2, GSTP1, ERCC1...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Li, Ziyu, Xing, Xiaofang, Shan, Fei, Li, Shuangxi, Li, Zhongwu, Xiao, Aitang, Xing, Zhaodong, Xue, Kan, Li, Zhemin, Hu, Ying, Jia, Yongning, Miao, Rulin, Zhang, Lianhai, Bu, Zhaode, Wu, Aiwen, Ji, Jiafu
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342428/
https://ncbi.nlm.nih.gov/pubmed/27487151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10961
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares